Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells

European Respiratory Journal

Volumn 34, Issue 3, 2009, Pages 721-730

  Stamatiou, R ^a   Paraskeva, E ^a   Boukas, K ^a   Gourgoulianis, K I ^a   Molyvdas, P A ^a   Hatziefthimiou, A A ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Airway smooth muscle cells; Autophagy; Azithromycin; Proliferation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 METHYLADENINE; 7 AMINODACTINOMYCIN; ALPHA SMOOTH MUSCLE ACTIN; AZITHROMYCIN; BECLIN 1; BETA ACTIN; CASPASE 3; CELL PROTEIN; LIGHT CHAIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; TRYPAN BLUE; UNCLASSIFIED DRUG; WORTMANNIN;

AIRWAY; ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL PROLIFERATION; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DEVICE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESPIRATORY FUNCTION; SMOOTH MUSCLE FIBER; STAINING; SYMPTOMATOLOGY; WESTERN BLOTTING;

ANIMALS; ANTI-BACTERIAL AGENTS; AUTOPHAGY; AZITHROMYCIN; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MYOCYTES, SMOOTH MUSCLE; RABBITS; TRACHEA;

EID: 70349152940     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00089407     Document Type: Article

References (35)

1. Kudoh S, Azuma A, Yamamoto M, et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998; 157: 1829-1832. (Pubitemid 28311266)
2. Oishi K, Sonoda F, Kobayashi S, et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airway of patients with chronic airway diseases. Infect Immun 1994; 62: 4145-4152. (Pubitemid 24301936)
3. Shirai T, Sato A, Chida K. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity. Intern Med 1995; 34: 469-474.
4. Miyatake H, Taki F, Taniguchi H, et al. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991; 99: 670-673.
5. Cazzola M, Salzillo A, Diamare F. Potential role of macrolides in the treatment of asthma. Monaldi Arch Chest Dis 2000; 55: 231-236. (Pubitemid 30636147)
6. Vignola A, Mirabella F, Costanzo G, et al. Airway remodelling in asthma. Chest 2003; 123: Suppl. 3, 417S-422S.
7. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164: S28-S38.
8. Tamaoki J, Tagaya E, Sakai A, et al. Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J Allergy Clin Immunol 1995; 95: 853-859.
9. Tagaya E, Tamaoki J, Konno K. Erythromycin inhibits cholinergic neuro-effector transmission in canine airway smooth muscle. Res Commun Mol Pathol Pharmacol 1994; 85: 181-192. (Pubitemid 24281020)
10. Daenas C, Hatziefthimiou AA, Gourgoulianis KI, et al. Azithromycin has a direct relaxant effect on precontracted airway smooth muscle. Eur J Pharmacol 2006; 553: 280-287. (Pubitemid 44779608)
11. Takahashi Y, Shimizu T, Sakakura Y. Effects of indomethacin, dexamethasone, and erythromycin on endotoxin-induced intraepithelial mucus production of rat nasal epithelium. Ann Otol Rhinol Laryngol 1997; 106: 683-687. (Pubitemid 27353504)
12. Tomita H, Osanai T, Toki T, et al. Roxithromycin is an inhibitor of human coronary artery smooth muscle cells proliferation: a potential ability to prevent coronary heart disease. Atherosclerosis 2005; 182: 87-95. (Pubitemid 41188373)
13. Fujitani Y, Trifilieff A. In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. Am J Respir Crit Care Med 2003; 167: 193-198.
14. Mizunoe S, Kadota J, Tokimatsu I, et al. Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. Int Immunopharmacol 2004; 4: 1201-1207. (Pubitemid 38900856)
15. Chachami G, Simos G, Hatziefthimiou A, et al. Cobalt induces hypoxia-inducible factor-1a expression in airway smooth muscle cells by a reactive oxygen species- and PI3K-dependent mechanism. Am J Respir Cell Mol Biol 2004; 31: 544-551. (Pubitemid 39463403)
16. Cory AH, Owen TC, Barltrop JA, et al. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991; 3: 207-212.
17. Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993; 303: 474-482.
18. Zelenin AV, Poletaev AI, Stepanova NG, et al. 7-Amino-actinomycin D as a specific fluorophore for DNA content analysis by laser flow cytometry. Cytometry 1984; 5: 348-354.
19. Schmid I, Krall WJ, Uittenbogaart CH, et al. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 1992; 13: 204-208.
20. Shen ZY, Xu LY, Li EM, et al. Autophagy and endocytosis in the amnion. J Struct Biol 2008; 162: 197-204.
21. Seglen PO, Gordon PB. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci USA 1982; 79: 1889-1892. (Pubitemid 12088533)
22. Petiot A, Ogier-Denis E, Blommaart EF, et al. Distinct classes of phosphatidylinositol 39-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000; 275: 992-998. (Pubitemid 30051145)
23. Ekici A, Ekici M, Erdemoglu AK. Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. J Asthma 2002; 39: 181-185. (Pubitemid 34464576)
24. Yates B, Murphy DM, Forrest IA, et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005; 172: 772-775. (Pubitemid 41324235)
25. Shimizu T, Shimizu S, Hattori R, et al. In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. Am J Respir Crit Care Med 2003; 168: 581-587.
26. Danesi R, Lupetti A, Barbara C, et al. Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. J Antimicrob Chemother 2003; 51: 939-945. (Pubitemid 36503427)
27. Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990; 181: 195-213.
28. Gozuacik D, Kimchi A. Autophagy and cell death. Curr Top Dev Biol 2007; 78: 217-245.
29. Cui Q, Tashiro S, Onodera S, et al. Augmentation of oridonin-induced apoptosis observed with reduced autophagy. J Pharmacol Sci 2006; 101: 230-239. (Pubitemid 44114317)
30. Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differ 2005; 12: Suppl. 2, 1528-1534. (Pubitemid 41553989)
31. Canu N, Tufi R, Serafino AL, et al. Role of the autophagic-lysosomal system on low potassium-induced apoptosis in cultured cerebellar granule cells. J Neurochem 2005; 92: 1228-1242. (Pubitemid 40344312)
32. Cui Q, Tashiro S, Onodera S, et al. Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells. Biol Pharm Bull 2007; 30: 859-864. (Pubitemid 46708626)
33. Yan CH, Yang YP, Qin ZH, et al. Autophagy is involved in cytotoxic effects of crotoxin in human breast cancer cell line MCF-7 cells. Acta Pharmacol Sin 2007; 28: 540-548. (Pubitemid 46496084)
34. Shacka J, Klocke B, Shibata M, et al. Bafilomycin A1 inhibits cloroquine-induced death of celebellar granule neurons. Mol Pharmacol 2006; 69: 1125-1136.
35. Fa N, Ronkart S, Schanck A, et al. Effect of the antibiotic azithromycin on thermotropic behavior of DOPC or DPPC bilayers. Chem Phys Lipids 2006; 144: 108-116. (Pubitemid 44537274)